Navigating the Challenges of Biomarker Testing in Oncology: Innovations for Low-Yield Samples

Biomarker analysis plays a pivotal role in cancer care and research, guiding the development of targeted therapies and enabling personalized treatment plans. While next-generation sequencing (NGS) has revolutionized the ability…

Continue Reading Navigating the Challenges of Biomarker Testing in Oncology: Innovations for Low-Yield Samples

Early Research on Two Tough Cancers

Pancreatic cancer took Alex Trebek, Michael Landon, Ruth Bader Ginsburg, Luciano Pavarotti, Steve Jobs,  Patrick Swayze, and my dear friend Amy. Glioblastoma (GBM) took Senators John McCain and Ted Kennedy,…

Continue Reading Early Research on Two Tough Cancers

The Unspoken Guilt of Living

Editor's Note: Patient Worthy is honored to share this story from our friends at Elephants & Tea. To see the article in its original form, please click here. Original author…

Continue Reading The Unspoken Guilt of Living

And the Good News is . . .Cancer Survivors in the United States are Projected to Exceed 22 million people by 2035

Here's a more detailed explanation. The newest American Cancer Society study just released suggests that a diagnosis of cancer is no longer a death sentence. According to a recent U.S.…

Continue Reading And the Good News is . . .Cancer Survivors in the United States are Projected to Exceed 22 million people by 2035
Research Breakthrough: Scientists May Have Discovered How Tumor Cells Outwit the Immune System
source: pixabay.com

Research Breakthrough: Scientists May Have Discovered How Tumor Cells Outwit the Immune System

Editor's Note: Chronic conditions and rare diseases don't discriminate, Patient Worthy and its partners are interested in amplifying the voices of those from all identities and backgrounds. If you have…

Continue Reading Research Breakthrough: Scientists May Have Discovered How Tumor Cells Outwit the Immune System
Carisma Therapeutics is Developing CT-0508 to Target HER2 Positive Cancers
source: shutterstock.com

Carisma Therapeutics is Developing CT-0508 to Target HER2 Positive Cancers

Carisma Therapeutics, the manufacturer of CT-0508, issued a press release stating that researchers are conducting a combination study using CAR-M cell therapy plus Keytruda (pembrolizumab) in the treatment of overexpressing…

Continue Reading Carisma Therapeutics is Developing CT-0508 to Target HER2 Positive Cancers
ASCO Member Testifies Before Senate Committee on Current Nationwide Shortage of Certain Cancer Drugs
source: unsplash.com

ASCO Member Testifies Before Senate Committee on Current Nationwide Shortage of Certain Cancer Drugs

According to a recent American Society of Clinical Oncology (ASCO) press release, Dr. Jason Westin provided testimony regarding a nationwide shortage of cancer drugs, numbering more than 15 on the…

Continue Reading ASCO Member Testifies Before Senate Committee on Current Nationwide Shortage of Certain Cancer Drugs

Study Shows an Average of 4 1/2 Minutes of Vigorous Exercise May Reduce the Risk of Cancer by 32%

The words ‘vigorous exercise’ usually bring to mind running marathons or playing pickleball. Inside Precision Medicine reports that researchers at a Sydney, Australia University tracked the daily activity of more…

Continue Reading Study Shows an Average of 4 1/2 Minutes of Vigorous Exercise May Reduce the Risk of Cancer by 32%